Regeneron Pharmaceuticals (NASDAQ:REGN) PT Lowered to $1,050.00 at Wells Fargo & Company
Regeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report) had its price target decreased by Wells Fargo & Company from $1,200.00 to $1,050.00 in a research note issued on Tuesday, Benzinga reports. The firm presently has an “overweight” rating on the biopharmaceutical company’s stock. Wells Fargo & Company‘s price objective would suggest a potential upside of 9.11% […]
More Stories
The Hain Celestial Group (NASDAQ:HAIN) Shares Down 3.6% – Time to Sell?
Shares of The Hain Celestial Group, Inc. (NASDAQ:HAIN – Get Free Report) were down 3.6% during trading on Monday ....
STEP Energy Services Ltd. (TSE:STEP) Given Average Rating of “Moderate Buy” by Brokerages
Shares of STEP Energy Services Ltd. (TSE:STEP – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy”...
Scotiabank Lowers Freeport-McMoRan (NYSE:FCX) Price Target to $48.00
Freeport-McMoRan (NYSE:FCX – Get Free Report) had its target price cut by investment analysts at Scotiabank from $52.00 to $48.00...
Kings Path Partners LLC Takes Position in Invesco NASDAQ 100 ETF (NASDAQ:QQQM)
Kings Path Partners LLC bought a new position in shares of Invesco NASDAQ 100 ETF (NASDAQ:QQQM – Free Report) in...
Iowa State Bank Acquires 120 Shares of Eli Lilly and Company (NYSE:LLY)
Iowa State Bank grew its stake in Eli Lilly and Company (NYSE:LLY – Free Report) by 2.1% during the fourth...
Occidental Petroleum (NYSE:OXY) Trading Up 1.5% – What’s Next?
Shares of Occidental Petroleum Co. (NYSE:OXY – Get Free Report) rose 1.5% during mid-day trading on Monday . The stock...